These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Therapy for children with Shiga toxin-E. coli-associated hemolytic uremic syndrome]. Ito K; Hattori M; Matsumoto N Nihon Rinsho; 2002 Jun; 60(6):1126-30. PubMed ID: 12078084 [TBL] [Abstract][Full Text] [Related]
16. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452 [TBL] [Abstract][Full Text] [Related]
17. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Orth D; Grif K; Khan AB; Naim A; Dierich MP; Würzner R Diagn Microbiol Infect Dis; 2007 Nov; 59(3):235-42. PubMed ID: 17931818 [TBL] [Abstract][Full Text] [Related]
18. New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. Karch H; Friedrich AW; Gerber A; Zimmerhackl LB; Schmidt MA; Bielaszewska M Semin Thromb Hemost; 2006 Mar; 32(2):105-12. PubMed ID: 16575685 [TBL] [Abstract][Full Text] [Related]
19. Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. Fremeaux-Bacchi V; Moulton EA; Kavanagh D; Dragon-Durey MA; Blouin J; Caudy A; Arzouk N; Cleper R; Francois M; Guest G; Pourrat J; Seligman R; Fridman WH; Loirat C; Atkinson JP J Am Soc Nephrol; 2006 Jul; 17(7):2017-25. PubMed ID: 16762990 [TBL] [Abstract][Full Text] [Related]
20. Atypical hemolytic uremic syndrome: update on the complement system and what is new. Hirt-Minkowski P; Dickenmann M; Schifferli JA Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]